Cargando…

Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment

Open spina bifida or myelomeningocele (MMC) is a devastating neurologic congenital defect characterized by primary failure of neural tube closure of the spinal column during the embryologic period. Cerebrospinal fluid leak caused by the MMC spinal defect in the developing fetus can result in a const...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatu, Rigwed R., Oria, Marc, Rao, Marepalli B., Peiro, Jose L., Lin, Chia-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913814/
https://www.ncbi.nlm.nih.gov/pubmed/35273223
http://dx.doi.org/10.1038/s41598-022-07681-8
_version_ 1784667537180459008
author Tatu, Rigwed R.
Oria, Marc
Rao, Marepalli B.
Peiro, Jose L.
Lin, Chia-Ying
author_facet Tatu, Rigwed R.
Oria, Marc
Rao, Marepalli B.
Peiro, Jose L.
Lin, Chia-Ying
author_sort Tatu, Rigwed R.
collection PubMed
description Open spina bifida or myelomeningocele (MMC) is a devastating neurologic congenital defect characterized by primary failure of neural tube closure of the spinal column during the embryologic period. Cerebrospinal fluid leak caused by the MMC spinal defect in the developing fetus can result in a constellation of encephalic anomalies that include hindbrain herniation and hydrocephalus. The exposure of extruded spinal cord to amniotic fluid also poses a significant risk for inducing partial or complete paralysis of the body parts beneath the spinal aperture by progressive spinal cord damage in-utero. A randomized trial demonstrated that prenatal repair by fetal surgery, sometimes using patches, to cover the exposed spinal cord with a watertight barrier is effective in reducing the postnatal neurologic morbidity as evidenced by decreased incidence and severity of postnatal hydrocephalus and the reduced need for ventricular-peritoneal shunting. Currently, the use of inert or collagen-based patches are associated with high costs and inadequate structural properties. Specifically, the inert patches do not degrade after implantation, causing the need for a post-natal removal surgery associated with trauma for the newborn. Our present study is aimed towards in-vitro degradation studies of a newly designed patch, which potentially can serve as a superior alternative to existing patches for MMC repair. This novel patch was fabricated by blending poly(l-lactic acid) and poly(ε-caprolactone). The 16-week degradation study in amniotic fluid was focused on tracking changes in crystallinity and mechanical properties. An additional set of designed patches was exposed to phosphate-buffered saline (PBS), as a time-paired control. Crystallinity studies indicate the progress of hydrolytic degradation of the patch in both media, with a preference to bulk erosion in phosphate buffered saline and surface erosion in amniotic fluid. Mechanical testing results establish that patch integrity is not compromised up to 16 weeks of exposure either to body fluids analog (PBS) or to amniotic fluid.
format Online
Article
Text
id pubmed-8913814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89138142022-03-14 Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment Tatu, Rigwed R. Oria, Marc Rao, Marepalli B. Peiro, Jose L. Lin, Chia-Ying Sci Rep Article Open spina bifida or myelomeningocele (MMC) is a devastating neurologic congenital defect characterized by primary failure of neural tube closure of the spinal column during the embryologic period. Cerebrospinal fluid leak caused by the MMC spinal defect in the developing fetus can result in a constellation of encephalic anomalies that include hindbrain herniation and hydrocephalus. The exposure of extruded spinal cord to amniotic fluid also poses a significant risk for inducing partial or complete paralysis of the body parts beneath the spinal aperture by progressive spinal cord damage in-utero. A randomized trial demonstrated that prenatal repair by fetal surgery, sometimes using patches, to cover the exposed spinal cord with a watertight barrier is effective in reducing the postnatal neurologic morbidity as evidenced by decreased incidence and severity of postnatal hydrocephalus and the reduced need for ventricular-peritoneal shunting. Currently, the use of inert or collagen-based patches are associated with high costs and inadequate structural properties. Specifically, the inert patches do not degrade after implantation, causing the need for a post-natal removal surgery associated with trauma for the newborn. Our present study is aimed towards in-vitro degradation studies of a newly designed patch, which potentially can serve as a superior alternative to existing patches for MMC repair. This novel patch was fabricated by blending poly(l-lactic acid) and poly(ε-caprolactone). The 16-week degradation study in amniotic fluid was focused on tracking changes in crystallinity and mechanical properties. An additional set of designed patches was exposed to phosphate-buffered saline (PBS), as a time-paired control. Crystallinity studies indicate the progress of hydrolytic degradation of the patch in both media, with a preference to bulk erosion in phosphate buffered saline and surface erosion in amniotic fluid. Mechanical testing results establish that patch integrity is not compromised up to 16 weeks of exposure either to body fluids analog (PBS) or to amniotic fluid. Nature Publishing Group UK 2022-03-10 /pmc/articles/PMC8913814/ /pubmed/35273223 http://dx.doi.org/10.1038/s41598-022-07681-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Tatu, Rigwed R.
Oria, Marc
Rao, Marepalli B.
Peiro, Jose L.
Lin, Chia-Ying
Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
title Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
title_full Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
title_fullStr Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
title_full_unstemmed Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
title_short Biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
title_sort biodegradation of poly(l-lactic acid) and poly(ε-caprolactone) patches by human amniotic fluid in an in-vitro simulated fetal environment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913814/
https://www.ncbi.nlm.nih.gov/pubmed/35273223
http://dx.doi.org/10.1038/s41598-022-07681-8
work_keys_str_mv AT taturigwedr biodegradationofpolyllacticacidandpolyecaprolactonepatchesbyhumanamnioticfluidinaninvitrosimulatedfetalenvironment
AT oriamarc biodegradationofpolyllacticacidandpolyecaprolactonepatchesbyhumanamnioticfluidinaninvitrosimulatedfetalenvironment
AT raomarepallib biodegradationofpolyllacticacidandpolyecaprolactonepatchesbyhumanamnioticfluidinaninvitrosimulatedfetalenvironment
AT peirojosel biodegradationofpolyllacticacidandpolyecaprolactonepatchesbyhumanamnioticfluidinaninvitrosimulatedfetalenvironment
AT linchiaying biodegradationofpolyllacticacidandpolyecaprolactonepatchesbyhumanamnioticfluidinaninvitrosimulatedfetalenvironment